Immunological and inflammatory profiles in mild and severe cases of COVID-19 - Song, Jin-Wen; Zhang, Chao; Fan, Xing; Meng, Fan-Ping; Xu, Zhe; Xia, Peng; Cao, Wen-Jing; Yang, Tao; Dai, Xiao-Peng; Wang, Si-Yu; Xu, Ruo-Nan; Jiang, Tian-Jun; et al. (Nature communications, 2020)
Keywords: 13/1; 13/21; 13/31; 13/51; 631/250/254; 631/250/255/2514; 631/250/256/2516; Adult; Aged; Aged, 80 and over; Betacoronavirus - immunology; Betacoronavirus - pathogenicity; Biomarkers - metabolism; CD4 antigen; CD4-Positive T-Lymphocytes - immunology; CD4-Positive T-Lymphocytes - pathology; CD8 antigen; CD8-Positive T-Lymphocytes - immunology; CD8-Positive T-Lymphocytes - pathology; Cell activation; Chemotaxis, Leukocyte; China - epidemiology; Coronavirus Infections - blood; Coronavirus Infections - immunology; Coronavirus Infections - pathology; Coronavirus Infections - virology; Coronaviruses; COVID-19; Cytokines - blood; Cytotoxicity; Epidemiology; Female; Humanities and Social Sciences; Humans; Immune system; Immunology; Inflammation; Killer Cells, Natural - immunology; Killer Cells, Natural - pathology; Leukocyte Count; Lung - immunology; Lung - virology; Lymphocyte Activation; Lymphocytes; Lymphocytes T; Lymphopenia; Macrophages; Male; Middle Aged; multidisciplinary; Pandemics; Pathogenesis; Patients; Pneumonia, Viral - blood; Pneumonia, Viral - immunology; Pneumonia, Viral - pathology; Pneumonia, Viral - virology; Ribonucleic acid; RNA; SARS-CoV-2; Science; Science (multidisciplinary); Severe acute respiratory syndrome coronavirus 2; Therapeutic applications; Toxicity; Viral diseases; China